Showing results (31-40 of 43) with videos related to
Sort By:
Pageof 5
Clinical Lymphoma, Myeloma & Leukemia|September 10, 2025
Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation in Older Patients Aged 65 Years and Above With MyelofibrosisMoazzam Shahzad, Muhammad Kashif Amin, Sohaib Irfan, et al.Frontiers in Oncology|October 24, 2022
Outcomes with mismatched unrelated donor allogeneic hematopoietic stem cell transplantation in adults: A systematic review and meta-analysisMuhammad Umair Mushtaq, Moazzam Shahzad, Ezza Tariq, et al.Leukemia & Lymphoma|October 25, 2022
Use of endpoints in phase III randomized controlled trials for acute myeloid leukemia over the last 15 years: a systematic reviewMoazzam Shahzad, Sibgha Gull Chaudhary, Ezza Tariq, et al.Gene|June 23, 2023
Differential expression of SLITRK6 gene as a potential therapeutic target for urothelial carcinoma in particular upper tract cancerMujahid A Mir, Arshad A Pandith, Sheikh Mansoor, et al.Leukemia & Lymphoma|February 10, 2022
Gender disparities in the National Institutes of Health funding for hematologic malignancies and cellular therapiesRaheel Sufian Siddiqui, Sibgha Gull Chaudhary, Moazzam Shahzad, et al.Hematology, Transfusion and Cell Therapy|November 28, 2025
Outcomes after bone marrow versus peripheral blood haploidentical hematopoietic cell transplantation using post-transplant cyclophosphamide-based graft-versus-host disease prophylaxisMuhammad Kashif Amin, Moazzam Shahzad, Abat Khan, et al.Frontiers in Immunology|May 11, 2023
Outcomes with chimeric antigen receptor t-cell therapy in relapsed or refractory acute myeloid leukemia: a systematic review and meta-analysisMoazzam Shahzad, Andrea Nguyen, Ali Hussain, et al.Clinical Lymphoma, Myeloma & Leukemia|January 22, 2023
Outcomes of Tyrosine Kinase Inhibitors Maintenance Therapy with or without Allogeneic Hematopoietic Stem Cell Transplantation in Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia in First Complete Remission: A Systematic Review and Meta-AnalysisMoazzam Shahzad, Ali Hussain, Ezza Tariq, et al.Critical Reviews in Oncology/Hematology|February 29, 2024
Outcomes with allogeneic hematopoietic stem cell transplantation in TP53-mutated myelodysplastic syndrome: A systematic review and meta-analysisMoazzam Shahzad, Qamar Iqbal, Ezza Tariq, et al.Hematology/Oncology and Stem Cell Therapy|April 1, 2024
Use of Endpoints in Phase III Randomized Controlled Trials for Hematopoietic Stem Cell Transplantation Over the Last 15 Years: A Systematic ReviewMoazzam Shahzad, Muhammad Fareed Khalid, Muhammad Kashif Amin, et al.Pageof 5